We’re thrilled to unveil our new state-of-the-art preclinical and early-clinical manufacturing facility to help you with your scientific needs. The IPRD Viral Vector and Gene Editing facility offers a foundation of support systems and technical expertise in a variety of modalities.

IPRD Director Pradeep Bhide noted, “Dr. Kantor’s leadership and expertise are helping IPRD build a powerful new capability for next-generation gene therapy research at FSU”

What We Offer:
1. Adeno, AAV, retroviral, and lentiviral vector design, cloning & packaging
2. CRISPR/Cas9 modifications, including conventional, epigenome, base, and prime editing
3. Customized shRNA and miR-shRNA libraries
4. Comprehensive collection of Optogenetic tools
5. Proprietary technologies, expert consultation, flexible options, fast turnaround time and researcher-friendly pricing

We add value to your research — every step of the way.